This product is for research use only, not for human use. We do not sell to patients.
| Size | Price | Stock |
|---|---|---|
| 1mg | $280 | To Be Confirmed |
Cat #: V46239 CAS #: 1198408-78-4 Purity ≥ 99%
Description: LDN-211904 oxalate (compound 32) is a potent and specific EphB3 inhibitor (antagonist) with IC50 of 0.079 µM. LDN-211904 oxalate displays good metabolic stability in mouse liver microsomes. LDN-211904 oxalate in combination with cetuximab effectively inhibits STAT3-activated CSC stemness and cetuximab resistance in CRC.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
| Molecular Weight (MW) | 444.868243932724 |
|---|---|
| Molecular Formula | C21H21CLN4O5 |
| CAS No. | 1198408-78-4 |
| Storage | Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Solvent volume to be added | Mass (the weight of a compound) | |||
|---|---|---|---|---|
| Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
| 1mM | 2.2479 mL | 11.2393 mL | 22.4786 mL | 44.9571 mL |
| 5mM | 0.4496 mL | 2.2479 mL | 4.4957 mL | 8.9914 mL |
| 10mM | 0.2248 mL | 1.1239 mL | 2.2479 mL | 4.4957 mL |
| 20mM | 0.1124 mL | 0.5620 mL | 1.1239 mL | 2.2479 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.



































